Mealey's IP/Tech - Federal Circuit Reverses Patent Invalidity Holdings

Mealey's IP/Tech - Federal Circuit Reverses Patent Invalidity Holdings

WASHINGTON, D.C. - Although affirming a Delaware federal judge's determination that two glaucoma drug patents were not infringed, the Federal Circuit U.S. Court of Appeals on March 18 nonetheless reversed that same judge's finding that the patents are invalid (Alcon Research Ltd. v. Barr Laboratories Inc., No. 12-1340, 341, Fed. Cir.).

Find full version on lexis Advance®
Access this news story on lexis.com®